These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 4608685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR.
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of splenectomy on fibrosarcoma "metastases" in lungs of mice.
    Milas L, Mujagic H.
    Int J Cancer; 1973 Jan 15; 11(1):186-90. PubMed ID: 4790835
    [No Abstract] [Full Text] [Related]

  • 7. Effect of thymectomy on tumor development and on T and B lymphocytes in tumor-bearing rats.
    Klobusická M, Koníková E, Novotná L.
    Neoplasma; 1979 Jan 15; 26(4):413-21. PubMed ID: 392324
    [Abstract] [Full Text] [Related]

  • 8. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection.
    Zarling JM, Tevethia SS.
    J Natl Cancer Inst; 1973 Jan 15; 50(1):149-57. PubMed ID: 4348219
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S, Nakao Y, Smith RT.
    Cancer Res; 1973 Oct 15; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice.
    Carnaud C, Hoch B, Trainin N.
    J Natl Cancer Inst; 1974 Feb 15; 52(2):395-9. PubMed ID: 4816002
    [No Abstract] [Full Text] [Related]

  • 13. Effective antitumor immunity following elimination of suppressor T cell function.
    Falk RE, Nossal NA, Falk JA.
    Surgery; 1978 Oct 15; 84(4):483-9. PubMed ID: 308706
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.
    Small M, Trainin N.
    Int J Cancer; 1975 Jun 15; 15(6):962-72. PubMed ID: 1150350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Spontaneous tumor regression. Experimental aspects.
    McLaughlin AP, Gittes RF.
    Urology; 1974 May 15; 3(5):544-51. PubMed ID: 4133855
    [No Abstract] [Full Text] [Related]

  • 17. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L, Hunter N, Mason K, Withers HR.
    Cancer Res; 1974 Jan 15; 34(1):61-71. PubMed ID: 4809463
    [No Abstract] [Full Text] [Related]

  • 18. Reduced transplantability of syngeneic tumors in rats immunized with allogeneic tumors.
    Kobayashi H, Gotoda E, Kuzumaki N, Takeichi N, Hosokawa M.
    Int J Cancer; 1974 Apr 15; 13(4):522-9. PubMed ID: 4366969
    [No Abstract] [Full Text] [Related]

  • 19. T cells and the immune response.
    Cantor H.
    Prog Biophys Mol Biol; 1972 Apr 15; 25():73-82. PubMed ID: 4145303
    [No Abstract] [Full Text] [Related]

  • 20. Suppressor cells prevent host resistance to tumor growth.
    Schechter B, Feldman M.
    Naturwissenschaften; 1979 Mar 15; 66(3):140-6. PubMed ID: 311899
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.